SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: weatherproof who wrote (38496)1/7/2017 11:45:30 AM
From: erickerickson4 Recommendations

Recommended By
btlbail1
drtom1234
ladyPI
patlawche11

  Read Replies (1) of 63290
 
These two quotes sum things up for me as well.

"I can only hope that what serves their interests aligns with mine."

and

"It dismays me greatly that we find ourselves at this crossroads..."

That said, my expectation is that venBio making a boatload of money here would benefit me too. That, unfortunately, is not necessarily true of current management. Current management can continue to receive handsome salaries and bonuses without any benefit for the rest of us.

As for this quote:
"VenBio's refraining from comment until they "get a look under the hood" doesn't necessarily work for me" "

I have been in the position of telling clients that very thing pretty often so I have some sympathy. Personally I'd like details as well. That said, venBio would risk anything specific they said weakening their position wrt the proxy fight or be insider info, neither are things I'd risk if I were them. They claim the don't have the latter, and the former is just bad negotiating.

Without doubt it's a leap of faith that I wish I didn't have to make. Unfortunately more of what we've seen for the last may years isn't acceptable to me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext